Considerations on the pricing system for medicinal products. Lourdes Fraguas Gadea
Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández
Public supply of medicines. Doctrine generated by the Spanish Review Commissions on Public Procurement as of the entry into force of the Spanish Lay 9/2017 ( 2018-2021).
Alberto Dorrego de Carlos and Marta Díaz García
Indirect taxation for the pharmaceutical sector. Brexit and COVID implications.
Aranxta de Luis Romero and Maria Teresa Deltell Ulecia
25º Pharmaceutical Lay Course Anniversary. Biomedicine. Public Health and medicinal products.
Fundación CEFI
Click here to access the publication
This post is also available in: Spanish
